LuciPem is indicated for the treatment of bile duct cancer with FGFR gene alterations. It is a precision oncology medicine used globally. Active Ingredient Pemigatinib inhibits fibroblast growth factor receptors (FGFR). Uses of LuciPem • Cholangiocarcinoma with FGFR mutation How LuciPem Works It blocks FGFR signaling pathways involved in tumor growth. How to Use LuciPem • Take as prescribed in cycles Possible Side Effects • Hyperphosphatemia • Fatigue • Dry mouth Precautions • Monitor phosphate levels • Eye exams recommended Safety Information Regular monitoring required. Storage • Store at room temperature • Protect from moisture and sunlight • Keep out of reach of children